We then determined whether WYC0209 inhibited the activation of ATR-Chk1 selectively in bladder cancer cells; thus, strategies capable of inhibiting the DNA damage responses (DDRs) may be effective in muscle-invasive bladder cancer. The gene discussed is CHEK1; the disease is urinary bladder carcinoma.